Article ID Journal Published Year Pages File Type
5825634 Clinical Therapeutics 2013 10 Pages PDF
Abstract
Age and serum creatinine level can be used at the bedside to determine the initial doses of ceftazidime. These Monte Carlo simulations highlight the need of a reappraisal of ceftazidime's use in burn patients. Doses between 3 and 16 g/d are proposed, taking into account the pathogens' MICs. However, for sepsis caused by a pathogen with an MIC ≥8 mg/L, an insufficient percentage of burn patients will reach the therapeutic target with the recommended dosages.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , , , , , , , , , , , ,